Ribonuclease A can be transformed into a dimeric ribonuclease with antitumor activity

J Biol Chem. 1994 Jul 1;269(26):17394-6.

Abstract

A cDNA coding for bovine pancreatic RNase A was mutagenized to insert a proline, a leucine, and 2 cysteine residues, i.e. the residues present at corresponding positions in the subunit of seminal RNase, the only dimeric RNase of the pancreatic-type superfamily. The mutant, expressed in Escherichia coli, eventually aggregated into catalytically active dimers. Like naturally dimeric seminal RNase, at equilibrium the mutant dimeric RNase A adopted two quaternary structures (one with an exchange of the N-terminal segments between partner subunits, the other with no exchange) and displayed a selective toxicity for malignant cells, absent in the monomeric, parent protein.

MeSH terms

  • 3T3 Cells
  • Animals
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / metabolism
  • Antineoplastic Agents / pharmacology*
  • Cattle
  • Cell Line, Transformed
  • Chromatography, Gel
  • DNA, Complementary
  • Electrophoresis, Polyacrylamide Gel
  • Escherichia coli
  • Mice
  • Mice, Inbred BALB C
  • Mutagenesis, Insertional
  • Pancreas / enzymology
  • Protein Conformation
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / metabolism
  • Recombinant Proteins / pharmacology
  • Ribonuclease, Pancreatic / chemistry
  • Ribonuclease, Pancreatic / genetics
  • Ribonuclease, Pancreatic / metabolism
  • Ribonuclease, Pancreatic / pharmacology*

Substances

  • Antineoplastic Agents
  • DNA, Complementary
  • Recombinant Proteins
  • Ribonuclease, Pancreatic